GCM
BRKR icon

Glenview Capital Management’s Bruker BRKR Stock Holding History

Glenview Capital Management’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-319,674
Closed -$10.4M – 61
2025
Q3 		$10.4M Buy
+319,674
New +$11.4M 0.23% 47

Other funds holding BRKR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $2.66B AUM 22.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

Glenview Capital Management's BRKR Position: Q4 2025 in Review

Glenview Capital Management sold out of Bruker (BRKR) in Q4 2025, closing a stake of 319,674 shares — an estimated $10.4M sold.

Glenview Capital Management first reported a position in BRKR in Q3 2025 and held it in 1 quarter. The position peaked at $10.4M in Q3 2025. 355 funds tracked by Wall St. Rank hold BRKR as of Q4 2025.

  • Glenview Capital Management reported no remaining Bruker position as of Q4 2025 after selling out during the quarter.
  • Glenview Capital Management sold 319,674 Bruker shares in Q4 2025, an estimated $10.4M.
  • Glenview Capital Management first reported a position in Bruker in Q3 2025 and held it in 1 quarter.
  • Glenview Capital Management's Bruker position peaked at $10.4M in Q3 2025.
  • 355 funds tracked by Wall St. Rank held Bruker as of Q4 2025.

Based on Glenview Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.